Two to six companies, their latest annual figures side by side, from SEC filings.
| Figure | NAMSNewAmsterdam Pharma Co N.V.FY2025 · Dec |
|---|---|
| Revenue | $22.50M |
| Revenue, yoy | −50.6% |
| Net income | $203.82M |
| Net income, yoy | +15.6% |
| Net margin | -905.7% |
| Free cash flow | $148.03M |
| FCF margin | -657.8% |
| EPS, diluted | $1.72 |
Add another company.